secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2024-06-13T23:59:59+00:00
Accession:  0001801170-24-000122
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health stockholders elect directors, approve say-on-pay, ratify EY as auditor at 2024 annual meeting
--------------------------------------------------------------------------------

- Elected Chelsea Clinton, Carladenise Armbrister Edwards, and Vivek Garipalli as Class III directors with over 937M votes each.
- Non-binding advisory vote to approve 2023 named executive officer compensation passed with ~950.6M for vs ~11M against.
- Ratified Ernst & Young LLP as independent auditor for 2024 with ~1.1B votes for, ~5.3M against.
- Broker non-votes of ~145.2M on director election and say-on-pay proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117024000122/0001801170-24-000122-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117024000122/clov-20240610.htm
  HTML page:      https://secwatch.observer/filing/0001801170-24-000122

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer